EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Fractional CO 2 Laser and Estrogen Ointment: A Novel Combined Approach for Treating Vulvar Lichen Sclerosus in Postmenopausal Women

Yuanyuan Chen, Haizhen He iD, Xiaodan Li, Haitang Chen, Lingxiao Huang, Jiajia Pan iD, Feifei Ni

Lasers in Surgery and Medicine · 2026-02 · 58 (2) · 79-92

DOI: 10.1002/lsm.70052 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Lasers in Surgery and Medicine, online erschienen am 17.12.2025. Verfasst von Yuanyuan Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecological Protection, The Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People's Hospital, Wen…. Hauptthemen laut MEDLINE: Lasers, Gas, Vulvar Lichen Sclerosus, Estrogens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Wenzhou Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vulvar lichen sclerosus (VLS) is a chronic inflammatory condition predominantly affecting postmenopausal women, often leading to significant discomfort and impaired quality of life. Current treatments, such as topical corticosteroids, have limitations in efficacy and long‐term safety. Fractional CO 2 laser therapy has emerged as a promising modality for managing VLS, but its combination with topical estrogen remains underexplored.

Objective

This study aimed to evaluate the efficacy and safety of combined fractional CO 2 laser and topical estrogen therapy in managing VLS in postmenopausal women.

Methods

A randomized controlled trial was conducted involving 60 postmenopausal women diagnosed with VLS. Participants were divided into two groups: the intervention group received fractional CO 2 laser therapy combined with topical estrogen ointment, while the control group received topical estrogen alone. Efficacy was defined as a significant reduction in vulvar lichen sclerosus symptom score (VLSSS), assessed at baseline, 3 months, and 6 months. Secondary outcomes included histopathological changes and patient‐reported quality of life measures.

Results

At both 3 months and 1 year after treatment, the intervention group showed a significant reduction in VLSSS compared to the control group ( p < 0.001). Histopathological analysis demonstrated reduced inflammation and fibrosis. Patient‐reported outcomes revealed significant improvements in sexual function (FSFI) and quality of life (CECA10) in the combined therapy group. Additionally, the recurrence rate at 1 year was significantly lower in the intervention group (17.14%) than in the control group (31.43%, p < 0.001). No severe adverse events were reported.

Limitations

The study's sample size was relatively small, and the follow‐up period was limited to 6 months, which may not capture long‐term outcomes. Additionally, the single‐center design may limit generalizability.

Conclusion

Combined fractional CO 2 laser and topical estrogen therapy is a safe and effective approach for managing VLS in postmenopausal women, offering significant symptom relief and improved quality of life. Further studies with larger cohorts and longer follow‐up are warranted to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lasers, GasVulvar Lichen SclerosusEstrogensHumansFemalePostmenopauseMiddle AgedCombined Modality TherapyOintmentsQuality of LifeAgedTreatment Outcome

Stichwörter der Autor:innen

fractional CO2 laserpostmenopausal womenrandomized controlled trialtopical estrogenvulvar lichen sclerosus

Substanzen

EstrogensOintments

Autor:innen und Institutionen

  • Department of Gynecological Protection, The Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People's Hospital, Wenzhou Maternal and Child Health Care Hospital, Wenzhou, China.
  • Department of Obstetrics, The Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People's Hospital, Wenzhou Maternal and Child Health Care Hospital, Wenzhou, China.
  • Department of Gynecology, The Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People's Hospital, Wenzhou Maternal and Child Health Care Hospital, Wenzhou, China.

ORCID-Profile: Haizhen He, Jiajia Pan

Förderung

  • Wenzhou Science and Technology Bureau

Zitieren

APA

Chen, Y., He, H., Li, X., Chen, H., Huang, L., Pan, J., & Ni, F. (2026). Fractional CO 2 Laser and Estrogen Ointment: A Novel Combined Approach for Treating Vulvar Lichen Sclerosus in Postmenopausal Women. Lasers in Surgery and Medicine, 58(2), 79-92. https://doi.org/10.1002/lsm.70052

Vancouver

Chen Y, He H, Li X, Chen H, Huang L, Pan J, et al. Fractional CO 2 Laser and Estrogen Ointment: A Novel Combined Approach for Treating Vulvar Lichen Sclerosus in Postmenopausal Women. Lasers in Surgery and Medicine. 2026;58(2):79-92. doi:10.1002/lsm.70052

BibTeX
@article{Chen2026,
  author = {Chen, Yuanyuan and He, Haizhen and Li, Xiaodan and Chen, Haitang and Huang, Lingxiao and Pan, Jiajia and Ni, Feifei},
  title = {Fractional CO 2 Laser and Estrogen Ointment: A Novel Combined Approach for Treating Vulvar Lichen Sclerosus in Postmenopausal Women},
  journal = {Lasers in Surgery and Medicine},
  year = {2026},
  volume = {58},
  number = {2},
  pages = {79--92},
  doi = {10.1002/lsm.70052}
}
Kostenlos starten →